Literature DB >> 19020958

Synthesis and characterization of Ag/Cu/HAP with platelet morphology.

Hui Yang1, Bingjuan Xiao, Ke-Wei Xu.   

Abstract

As a useful starting material in coating technology and preparation of HAP/polymers composites the platelet Ag/Cu/HAP was prepared using the solid solution of HAP reacting with the mix-solution of silver and copper nitrate. Its composition, microstructure and properties were characterized by means of X-ray diffraction (XRD), scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FTIR) and anti-bacterial or bacteriostatic tests. The results demonstrate that the prepared Ag/Cu/HAP crystal is mainly comprised of HAP phase with little whitelockite and silver phosphate, stable up to 600 degrees C and takes a platelet shape. At 750 degrees C, it is partially changed into whitelockite, calcium copper phosphate, silver oxide and silver phosphate. The platelet Ag/Cu/HAP crystal has a preferential orientation of a-axis below 600 degrees C, above which the growth in a-axis is greatly inhibited. The Ag/Cu/HAP has good crystallinity at 600 degrees C and is the most effective powder in resisting bacteria among the HAP powders investigated. The platelet Ag/Cu/HAP crystal can be good starting materials to make antibacterial polymers/HAP composites and HAP coatings.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19020958     DOI: 10.1007/s10856-008-3630-z

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  16 in total

Review 1.  Clinical applications of bone graft substitutes.

Authors:  S N Khan; E Tomin; J M Lane
Journal:  Orthop Clin North Am       Date:  2000-07       Impact factor: 2.472

Review 2.  Bone cells and matrices in orthopedic tissue engineering.

Authors:  J E Fleming; C N Cornell; G F Muschler
Journal:  Orthop Clin North Am       Date:  2000-07       Impact factor: 2.472

3.  Preparation of collagen/calcium phosphate multilayer sheet using enzymatic mineralization.

Authors:  Kiyoshi Yamauchi; Tatsuya Goda; Nobuyuki Takeuchi; H Einaga; Toshizumi Tanabe
Journal:  Biomaterials       Date:  2004-11       Impact factor: 12.479

4.  In vitro anti-bacterial and biological properties of magnetron co-sputtered silver-containing hydroxyapatite coating.

Authors:  W Chen; Y Liu; H S Courtney; M Bettenga; C M Agrawal; J D Bumgardner; J L Ong
Journal:  Biomaterials       Date:  2006-07-26       Impact factor: 12.479

5.  Antimicrobial effects and human gingival biocompatibility of hydroxyapatite sol-gel coatings.

Authors:  Ren-Jei Chung; Ming-Fa Hsieh; Chine-Wen Huang; Li-Hsiang Perng; Hsiao-Wei Wen; Tsung-Shune Chin
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2006-01       Impact factor: 3.368

6.  Biomaterial-centered infection: microbial adhesion versus tissue integration.

Authors:  A G Gristina
Journal:  Science       Date:  1987-09-25       Impact factor: 47.728

7.  Antibacterial and bioactive silver-containing Na2O x CaO x 2SiO2 glass prepared by sol-gel method.

Authors:  M Catauro; M G Raucci; F De Gaetano; A Marotta
Journal:  J Mater Sci Mater Med       Date:  2004-07       Impact factor: 3.896

Review 8.  Infections associated with prosthetic devices: magnitude of the problem.

Authors:  B Sugarman; E J Young
Journal:  Infect Dis Clin North Am       Date:  1989-06       Impact factor: 5.982

9.  Antimicrobial effects of metal ions (Ag+, Cu2+, Zn2+) in hydroxyapatite.

Authors:  T N Kim; Q L Feng; J O Kim; J Wu; H Wang; G C Chen; F Z Cui
Journal:  J Mater Sci Mater Med       Date:  1998-03       Impact factor: 3.896

10.  Development and characterisation of silver-doped bioactive glass-coated sutures for tissue engineering and wound healing applications.

Authors:  J J Blaker; S N Nazhat; A R Boccaccini
Journal:  Biomaterials       Date:  2004 Mar-Apr       Impact factor: 12.479

View more
  1 in total

1.  The antimicrobial effect of open-cell silver foams.

Authors:  S Asavavisithchai; A Oonpraderm; U Rungsardthong Ruktanonchai
Journal:  J Mater Sci Mater Med       Date:  2010-04       Impact factor: 3.896

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.